Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Myasthenia Gravis Disease market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Myasthenia Gravis Diseasemarket, defines the market attractiveness level of Myasthenia Gravis Disease market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Myasthenia Gravis Disease industry, describes the types of Myasthenia Gravis Disease market, the applications of major players and the market size, and deeply analyzes the current situation of the global Myasthenia Gravis Disease market and the development prospects and opportunities of Myasthenia Gravis Disease industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Myasthenia Gravis Disease market in Chapter 13.
By Player:
Apotex
Novartis
Bristol-Myers Squibb
Fresenius Kabi
Cipla
Roche
AbbVie
Biogen
Sun Pharmaceuticals
RPG Life Sciences
Piramal Healthcare
Teva Pharmaceutical
Bausch Health Companies Inc
GlaxoSmithKline
By Type:
Imaging
Blood Tests
Electrodiagnostic
Edrophonium Test
Pulmonary Function Test
By End-User:
Hospitals
Clinics
Academic Research Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Myasthenia Gravis Disease Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Myasthenia Gravis Disease Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Myasthenia Gravis Disease Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Myasthenia Gravis Disease Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Myasthenia Gravis Disease Market Analysis and Outlook to 2022
-
7.1 Global Myasthenia Gravis Disease Consumption (2017-2022)
-
7.2 United States Myasthenia Gravis Disease Consumption (2017-2022)
-
7.3 Europe Myasthenia Gravis Disease Consumption (2017-2022)
-
7.4 China Myasthenia Gravis Disease Consumption (2017-2022)
-
7.5 Japan Myasthenia Gravis Disease Consumption (2017-2022)
-
7.6 India Myasthenia Gravis Disease Consumption (2017-2022)
-
7.7 South Korea Myasthenia Gravis Disease Consumption (2017-2022)
8 Region and Country-wise Myasthenia Gravis Disease Market Analysis and Outlook to 2028
-
8.1 Global Myasthenia Gravis Disease Consumption Forecast (2022-2028)
-
8.2 United States Myasthenia Gravis Disease Consumption Forecast (2022-2028)
-
8.3 Europe Myasthenia Gravis Disease Consumption Forecast (2022-2028)
-
8.4 China Myasthenia Gravis Disease Consumption Forecast (2022-2028)
-
8.5 Japan Myasthenia Gravis Disease Consumption Forecast (2022-2028)
-
8.6 India Myasthenia Gravis Disease Consumption Forecast (2022-2028)
-
8.7 South Korea Myasthenia Gravis Disease Consumption Forecast (2022-2028)
9 Global Myasthenia Gravis Disease Market Outlook by Types and Applications to 2022
-
9.1 Global Myasthenia Gravis Disease Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Imaging Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Blood Tests Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Electrodiagnostic Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Edrophonium Test Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Pulmonary Function Test Consumption and Growth Rate (2017-2022)
-
9.2 Global Myasthenia Gravis Disease Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Academic Research Institutes Consumption and Growth Rate (2017-2022)
10 Global Myasthenia Gravis Disease Market Outlook by Types and Applications to 2028
-
10.1 Global Myasthenia Gravis Disease Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Imaging Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Blood Tests Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Electrodiagnostic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Edrophonium Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Pulmonary Function Test Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Myasthenia Gravis Disease Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Academic Research Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Myasthenia Gravis Disease Import and Export Analysis (Top 5 Countries)
-
11.1 Global Myasthenia Gravis Disease Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Myasthenia Gravis Disease Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Myasthenia Gravis Disease Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Myasthenia Gravis Disease Market Competitive Analysis
-
14.1 Apotex
-
14.1.1 Apotex Company Details
-
14.1.2 Apotex Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Apotex Myasthenia Gravis Disease Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Myasthenia Gravis Disease Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Myasthenia Gravis Disease Product and Service
-
14.4 Fresenius Kabi
-
14.4.1 Fresenius Kabi Company Details
-
14.4.2 Fresenius Kabi Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Fresenius Kabi Myasthenia Gravis Disease Product and Service
-
14.5 Cipla
-
14.5.1 Cipla Company Details
-
14.5.2 Cipla Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cipla Myasthenia Gravis Disease Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Myasthenia Gravis Disease Product and Service
-
14.7 AbbVie
-
14.7.1 AbbVie Company Details
-
14.7.2 AbbVie Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AbbVie Myasthenia Gravis Disease Product and Service
-
14.8 Biogen
-
14.8.1 Biogen Company Details
-
14.8.2 Biogen Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Biogen Myasthenia Gravis Disease Product and Service
-
14.9 Sun Pharmaceuticals
-
14.9.1 Sun Pharmaceuticals Company Details
-
14.9.2 Sun Pharmaceuticals Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sun Pharmaceuticals Myasthenia Gravis Disease Product and Service
-
14.10 RPG Life Sciences
-
14.10.1 RPG Life Sciences Company Details
-
14.10.2 RPG Life Sciences Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 RPG Life Sciences Myasthenia Gravis Disease Product and Service
-
14.11 Piramal Healthcare
-
14.11.1 Piramal Healthcare Company Details
-
14.11.2 Piramal Healthcare Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Piramal Healthcare Myasthenia Gravis Disease Product and Service
-
14.12 Teva Pharmaceutical
-
14.12.1 Teva Pharmaceutical Company Details
-
14.12.2 Teva Pharmaceutical Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Teva Pharmaceutical Myasthenia Gravis Disease Product and Service
-
14.13 Bausch Health Companies Inc
-
14.13.1 Bausch Health Companies Inc Company Details
-
14.13.2 Bausch Health Companies Inc Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Bausch Health Companies Inc Myasthenia Gravis Disease Product and Service
-
14.14 GlaxoSmithKline
-
14.14.1 GlaxoSmithKline Company Details
-
14.14.2 GlaxoSmithKline Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 GlaxoSmithKline Myasthenia Gravis Disease Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Myasthenia Gravis Disease
-
Figure Myasthenia Gravis Disease Picture
-
Table Global Myasthenia Gravis Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Myasthenia Gravis Disease Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Myasthenia Gravis Disease Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Myasthenia Gravis Disease Consumption by Country (2017-2022)
-
Figure United States Myasthenia Gravis Disease Consumption and Growth Rate (2017-2022)
-
Table Europe Myasthenia Gravis Disease Consumption and Growth Rate (2017-2022)
-
Figure China Myasthenia Gravis Disease Consumption and Growth Rate (2017-2022)
-
Figure Japan Myasthenia Gravis Disease Consumption and Growth Rate (2017-2022)
-
Figure India Myasthenia Gravis Disease Consumption and Growth Rate (2017-2022)
-
Figure South Korea Myasthenia Gravis Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Myasthenia Gravis Disease Consumption Forecast by Country (2022-2028)
-
Figure United States Myasthenia Gravis Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Myasthenia Gravis Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Myasthenia Gravis Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Myasthenia Gravis Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Myasthenia Gravis Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Myasthenia Gravis Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Imaging Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Tests Consumption and Growth Rate (2017-2022)
-
Figure Global Electrodiagnostic Consumption and Growth Rate (2017-2022)
-
Figure Global Edrophonium Test Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary Function Test Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Academic Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Imaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Tests Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Electrodiagnostic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Edrophonium Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pulmonary Function Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Myasthenia Gravis Disease Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Myasthenia Gravis Disease Export by Region (Top 5 Countries) (2017-2028)
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Myasthenia Gravis Disease Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Myasthenia Gravis Disease Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Myasthenia Gravis Disease Product and Service
-
Table Fresenius Kabi (Foundation Year, Company Profile and etc.)
-
Table Fresenius Kabi Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Kabi Myasthenia Gravis Disease Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Myasthenia Gravis Disease Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Myasthenia Gravis Disease Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Myasthenia Gravis Disease Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Myasthenia Gravis Disease Product and Service
-
Table Sun Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceuticals Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceuticals Myasthenia Gravis Disease Product and Service
-
Table RPG Life Sciences (Foundation Year, Company Profile and etc.)
-
Table RPG Life Sciences Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table RPG Life Sciences Myasthenia Gravis Disease Product and Service
-
Table Piramal Healthcare (Foundation Year, Company Profile and etc.)
-
Table Piramal Healthcare Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Piramal Healthcare Myasthenia Gravis Disease Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Myasthenia Gravis Disease Product and Service
-
Table Bausch Health Companies Inc (Foundation Year, Company Profile and etc.)
-
Table Bausch Health Companies Inc Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bausch Health Companies Inc Myasthenia Gravis Disease Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Myasthenia Gravis Disease Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Myasthenia Gravis Disease Product and Service
-
